Phoenix DX Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Phoenix DX Ltd - overview
Location
Manchester, England, UK
Primary Industry
Biotechnology
About
Based in Manchester, UK, Phoenix DX Ltd (LIG Biowise Ltd) is a molecular diagnostic company that provides point-of-care diagnostics for detecting infectious diseases in the respiratory tract.
Current Investors
Phoenix Bridge
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.lig-biowise.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Phoenix DX Ltd - financials
| Fiscal Year Ended | Dec 31, 2020 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Phoenix DX Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.